Aims: Autophagy has been regarded as a promising therapeutic target for spinal cord injury (SCI). Erythropoietin (EPO) has been demonstrated to exhibit neuroprotective effects in the central nervous system (CNS); however, the molecular mechanisms of its protection against SCI remain unknown. This study aims to investigate whether the neuroprotective effects of EPO on SCI are mediated by autophagy via AMPactivated protein kinase (AMPK) signaling pathways. 
| INTRODUC TI ON
Spinal cord injury (SCI) is a disastrous insult of the central nervous system (CNS) with few restorative treatments 1 . The pathological course of SCI consists of primary and secondary injury 2 . In general, secondary injury which incorporates apoptosis, hypoxia, oxidative stress, inflammation, and glial scar formation is believed to evoke further damage following primary injury [3] [4] [5] . Although the therapeutic intervention against primary injury is inaccessible, secondary injury mechanisms could be manipulated, providing invaluable
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therapeutic targets for the cure of SCI 2, [6] [7] [8] . Autophagy is a catabolic process by which unwanted proteins and organelles are eliminated and recycled, playing an important role in intracellular homeostasis [9] [10] [11] . Recently, autophagy has been demonstrated to be an important therapeutic mechanism for injuries of CNS such as SCI and several CNS degeneration diseases such as Alzheimer's disease [12] [13] [14] .
Accumulating evidence has shown that autophagy is induced after SCI, and the impairment of autophagy has been addressed to aggravate the secondary injury [15] [16] [17] [18] . The AMP-activated protein kinase (AMPK) acts as an energy sensor responding to stress conditions such as oxidative stress and deprivation of nutrition, which also acts as a key player in autophagy [19] [20] [21] . The induction of autophagy via AMPK by several drugs such as metformin and resveratrol has recently been addressed to promote the functional recovery following SCI 22, 23 .
Erythropoietin has previously been reported to work in CNS in both physiological and pathological conditions [24] [25] [26] . Results from in vitro studies employing neurons or neuronal cell line have verified the EPO-induced protection against a variety of insults such as neurotoxicity, serum withdrawal, and neurotrophic factor deprivation 25, 27 .
Results from the models of cerebral ischemia, traumatic brain injury (TBI), and spinal cord ischemia suggest that EPO might exert protective action in these conditions [26] [27] [28] [29] . The possible mechanisms of the EPO's neuroprotection involve antiapoptosis 27, 30 , antiinflammatory 28, 31 , and antioxidation 31, 32 , yet the exact mechanisms remain unclear. The protective capacity of EPO has been previously shown to be dependent on AMPK in several conditions including neuroinflammation and oxidative stress 33, 34 . However, the roles of EPO in SCI, especially its action on AMPK signaling and autophagic activity, remain unknown.
This study examined the hypothesis that the neuroprotection of EPO on SCI may be mediated by autophagy via AMPK signaling pathways. We evaluated the effects of EPO on functional recovery after SCI. We found that EPO induced autophagy and activated AMPK activity in the injured spinal cords. Furthermore, we found that AMPK may be involved in the EPO-induced autophagy and beneficial action on SCI.
| MATERIAL S AND ME THODS

| Animals
Adult male Sprague-Dawley (SD) rats weighting 200-220 g were purchased from Animal Center of the Chinese Academy of Sciences.
All experiments were performed with reference to Guidelines for the Care and Use of Laboratory Animals from the National Institutes of Health and were approved by the Laboratory Animal Ethics
Committee of Wenzhou Medical University ( # WYDW-2015-0150).
| Spinal cord injury
Spinal cord injury was made by the compression of a bulldog clamp 35, 36 . Briefly, rats were anesthetized by injecting pentobarbital sodium (50 mg/kg) intraperitoneally. A laminectomy from T7 to T10 was performed. Spinal cord was subjected to the compression of a bulldog clamp (30 g force; Oscar, China) for 1 minute. After surgery, the bladder was manually evacuated twice daily. Rats in sham group were subjected to laminectomy alone. Saline or EPO was intraperitoneally injected immediately and 24 hours after surgery. The doses of EPO (1000 U/kg, 2000 U/kg) were based on previous studies 29, 37 and the instruction of manufacturers. To assess the role of the EPOinduced modulation of AMPK in its beneficial action on SCI, the animals subjected to SCI were also treated intraperitoneally with EPO or metformin (50 mg/kg) plus compound C (20 mg/kg) immediately and 24 hours after surgery. The doses of compound C and metformin are based on previous studies 22, [38] [39] [40] [41] and the instruction of manufacturers. Erythropoietin and metformin were purchased from Boyun Biotechnology (Shanghai, China). Compound C was sourced from Selleck Chemicals (Houston, TX, USA).
| Locomotion recovery assessment
The Basso, Beattie, and Bresnahan (BBB) locomotor rating scale was used to evaluate the functional recovery at 1, 7, 14, and 28 days after surgery 42 . Three testers who were blinded to the grouping conducted these experiments, data from them averaged. The inclined plane test was utilized to objectively assess the function of hind limb 43 . In brief, rats were placed on an inclined plane whose angles were added at 5-degree interval. The maximum angle where a rat could hold for 5 seconds was recorded.
| Nissl staining
Spinal cord samples were collected at 28 days following surgery.
The rats were transcardially perfused with 0.1 mol/L PBS followed by 4% paraformaldehyde (PFA) at 28 days after injury. The lesioned spinal cords (10 mm in length) were obtained and immersed in 4%
PFA for 24 hours, transferred to 30% sucrose solution until they sank, and cut into 15-μm-thick transverse sections using a freezing microtome (Thermo, USA). Nissl staining was performed as previously described 36 . In brief, the sections were incubated with 0.1% 
| Autophagy flux monitoring
Cultures 
| Western blot analysis
The animals were sacrificed at 1, 3, and 7 days after surgery. PC12 cells were treated as indicated. Samples were homogenized in lysis buffer containing protease and phosphatase inhibitor cocktails.
The lysate was incubated for 25 minute at 4°C, followed by 18-min centrifuge at 15 000 g. Proteins were separated using SDS-PAGE, 
| Double immunofluorescence staining
The animals were sacrificed at 3 days after surgery. After perfused 
| Statistical analysis
Data were presented as mean ± SD and were analyzed with SPSS software 17.0 (SPSS Inc., IL, USA). The results were analyzed by oneway analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test. A P value <.05 was set to be statistically significant.
| RE SULTS
| Erythropoietin improves the functional recovery and decreases the loss of ventral motor neurons after SCI
To generate a traumatic spinal cord injury model, SD rats were subjected to compression injury on T9 spinal cords, and varying doses of EPO were administered to examine its therapeutic effects. Open-field locomotion testing showed that administering EPO effectively im- 
| Erythropoietin enhances the SCI-induced autophagy
As autophagy plays a critical role in the secondary injury mechanism of SCI [15] [16] [17] [18] , we examined whether the beneficial action of EPO on SCI was mediated by autophagy in our model system. Knowing that the conversion from LC3-I to LC3-II and expression of Beclin 1 are indispensable for the formation and expansion of autophagosomes 10 , we detected these autophagic markers at 1, 3, and 7 days after injury to examine the temporal pattern of autophagic activity.
The levels of LC3-II/LC3-I ratio and Beclin 1 were significantly increased after SCI, peaked at 3 days after injury, and fell slightly at 7 days after injury ( Figure S1A-C) .
Besides LC3 and Beclin 1, levels of autophagy substrates such as p62/SQSTM1 can also be used to monitor autophagic flux 10, 16 .
Elevated levels of p62, together with higher LC3-II/LC3-I ratio, might indicate a decrease in autophagosomes degradation due to the impairment of autophagic flux 16 . We therefore checked the expression of p62 after SCI. The levels of p62 were also increased in a time- Figure 3A ,C). P-mTOR/mTOR ratio was also elevated by SCI, whereas, it tended to be decreased by EPO treatment ( Figure 3A ,B).
To confirm mTOR activity, we have measured the level of p70S6K,the downstream signaling of mTOR. Similarly, p-p70S6K/p70S6K ratio was significantly elevated after SCI,whereas, EPO significantly suppressed the SCI-induced activation of p70S6K ( Figure 3A,B) . Taken together, these results suggest that EPO treatment may activate AMPK and inactivate mTOR in the injured spinal cords.
| Erythropoietin -induced autophagy is mediated by AMPK in the injured spinal cords
To assess the detailed roles of EPO-induced activation of AMPK in the induction of autophagy after SCI, the effects of compound 
| Inhibition of AMPK neutralizes the beneficial effects of EPO in rats after SCI
To further determine the role of the EPO-induced activation of AMPK in its beneficial action on SCI, the effects of compound C and metformin on motor neurons and locomotion recovery were assessed.
We found that treatment with compound C significantly blocked EPO-induced improvement of BBB scores as well as angles of inclined plane ( Figure 5A,B) . Metformin could mimic the effects of EPO, significantly improve the BBB scores as well as angles of inclined plane ( Figure 5A,B) . The EPO-induced increase in ventral motor neurons was also blocked by compound C (Figure 5C,D) . Metformin could mimic the effects of EPO, decrease the loss of neurons after SCI ( Figure 5C,D) .
Taken together, these data suggested that AMPK may play a critical role in EPO-induced beneficial action on SCI.
| Erythropoietin enhances the hypoxia-induced autophagy in an AMPK-dependent manner in PC12 cells
To validate the role of AMPK-dependent induction of autophagy in EPO's neuroprotection, we performed the in vitro study. PC12 cells (an extensively used neuronal cell line) were cultured in hypoxia condition as an in vitro neuronal injury model 48 . CCK8 assay showed that hypoxia significantly reduced the cell viability, whereas pretreatment with EPO for 2 hours prior to hypoxia attenuated this decrease of cell viability ( Figure 6A ). To further examine the protection of EPO on hypoxia-induced cell death through promoting autophagy, the autophagic markers were detected. As shown in Figure 6B -D, levels of LC3-II/LC3-I ratio, Beclin 1, and p62 were increased after hypoxia, whereas pretreatment with EPO for 2 hours prior to hypoxia further 
| D ISCUSS I ON
In the present study, we validated EPO's beneficial effects on SCI and found that EPO may induce autophagy and activate AMPK in the injured spinal cords. And more importantly, we found that AMPK may be involved in the EPO-induced autophagy and its beneficial effects on SCI. This study suggests that EPO may be a potential therapeutic drug for SCI targeting AMPK and autophagy.
Our results showed that either 1000 or 2000 U/kg EPO effectively improved the functional recovery following SCI, yet its therapeutic action was dose-dependent. The reported effective doses of EPO varied from 500 U/kg to 5000 U/kg 27, 29, 37 , which were
The Erythropoietin (EPO)-induced autophagy is mediated by AMP-activated protein kinase (AMPK) activation in the injured spinal cords. The animals subjected to SCI were intraperitoneally injected with EPO (2000 U/kg) or metformin (50 mg/kg) together with compound C (20 mg/kg) immediately and 24 h after surgery. The spinal cord tissues were collected at 3 d after injury. A-C, The protein levels of p-AMPK/AMPK, p-mTOR/mTOR, and p-p70S6K/p70S6K were determined by Western blotting. β-actin was used as the loading control. B-C, Histograms of the relative expression of p-AMPK/AMPK, p-mTOR/mTOR, and p-p70S6K/p70S6K. D, The protein levels of LC3II/I, Beclin 1, and p62 were determined by Western blotting. β-actin was used as the loading control. E-F, Histograms of the relative expression of LC3-II/I, Beclin 1, and p62. Data are mean ± SD, n = 5 per group. **P < .01, *P < .05 vs SCI + saline group, # P < .05 vs the SCI + EPO group consistent with our results. In the present study, we further validated EPO's beneficial effect by Nissl staining and count of ventral motor neurons.
Increasing evidence indicates that autophagy plays critical roles in neuroprotection 23, 49, 50 . Previous studies employing spinal cord contusion injury model have shown that levels of LC3 and Beclin 1 were increased and peaked at 7 or 10 days after injury 22, 51 , while studies employing hemi-section injury model showed that the increase in LC3 signals was detected as early as 4 hours and peaked at 3 days after hemi-section injury 52 . The inconsistency of temporal pattern of autophagy following SCI could be prompted by the difference in SCI models or injury severity 16, 53 . Under our experimental condition, autophagic activity was significantly enhanced after SCI, peaked at 3 days, and fell slightly at 7 days after injury. A novel finding of our study is that treatment with EPO further promotes autophagic activity under SCI condition.
AMP-activated protein kinase, which is a key regulator of energy metabolism, plays a critical role in the induction of autophagy 21, 46 .
The increase in AMP/ATP ratio in the state of stress can promote the phosphorylation and activation of AMPK and suppress the activation the mTOR, thus induces autophagy 19, 21, 45, 46 . AMP-activated protein kinase phosphorylation was increased after SCI under our experimental condition, yet mTOR activity was also increased. The identical between AMPK and mTOR activity may be caused by the distinction of antibodies or other unknown cause. A novel finding of the present study is that AMPK activity was upregulated by EPO under SCI condition, which could be mimicked by the positive control, metformin.
To Data are mean ± SD, n = 5 per group. **P < .01, *P < .05 vs SCI + saline group, ## P < .01, # P < .05 vs the SCI + EPO group F I G U R E 6 Erythropoietin (EPO) enhances the hypoxia-induced autophagy in an AMP-activated protein kinase-dependent manner in PC12 cells. PC12 cells were cultured under a conventional atmosphere for 24 h followed by an oxygen-free atmosphere of 95% N 2 and 5% CO 2 . Prior to hypoxia, experimental wells were treated with EPO (50 U/mL), or combined with compound C (5 μmol/L), or compound C (5 μmol/L) alone for 2 h. A, The cell viability was determined by CCK8 assay. B,The protein levels of LC3II/I, Beclin 1, and p62 were determined by Western blotting. β-actin was used as the loading control. C-D, Histograms of the relative expression of LC3-II/I, Beclin 1, and p62. E, Representative fluorescent images of PC12 cells incubated with tandem sensor RFP-GFP-LC3B kit and treated as indicated. F, The numbers of yellow puncta (autophagosomes) and red puncta (autolysosomes) in the merged images were counted. Data are mean ± SD, n = 4 per group. **P < .01, *P < .05 vs hypoxia group, # P < .05 vs the hypoxia + EPO group resveratrol 23 has recently been addressed to promote the functional recovery following SCI. On the other side, EPO was reported to induce AMPK-mediated therapeutic action in microglial cells and adipocytes 33, 34 . In our condition, inhibition of AMPK with compound C could neutralize the beneficial effects of EPO in rats with SCI. Our findings suggest that AMPK play at least partial role in EPO-induced beneficial effects on SCI.
The present study had several limitations. To reconfirm the role of AMPK in EPO's action following SCI, experiments with AMPK shRNA or AMPK KO mice are needed to reconfirm our findings in the future 54 . Autophagy was assessed only by the ratio of LC3-II/LC3-I, levels of Beclin 1, and p62, added tools such as electron microscopic analysis are needed 55 . Also, as autophagy is a dynamic process, examining p62 only is not adequate to monitor autophagy flux because it is difficult to distinguish it happened on the process of autophagy formation or of autophagy degradation. Therefore, further methods such as tandem fluorescent-tagged LC3 (mRFP-EGFP-LC3) can be used in the in vivo study 55 .
Overall, EPO has a therapeutic effect on SCI, at least in part, through the AMPK-dependent induction of autophagy. These novel mechanisms of EPO's neuroprotection may provide invaluable therapeutic target for the exploitation of potential therapeutic strategies for SCI.
ACK N OWLED G M ENTS
This study was supported by the Natural Science Foundation of Zhejiang Province (LR18C090001) and National Natural Science Foundation (81571190, 31671071, 81771348, 81371350, 81701202).
CO N FLI C T O F I NTE R E S T S
The authors declare no conflict of interests.
O RCI D
Zhi-Hui Huang http://orcid.org/0000-0002-1927-0946
